Literature DB >> 17614360

Partial derivative-based sensitivity analysis of models describing target-mediated drug disposition.

Anson K Abraham1, Wojciech Krzyzanski, Donald E Mager.   

Abstract

Sensitivity analysis is commonly used to characterize the effects of parameter perturbations on model output. One use for the approach is the optimization of an experimental design enabling estimation of model parameters with improved accuracy. The primary objective of this study is to conduct a sensitivity analysis of selected target-mediated pharmacokinetic models, ascertain the effect of parameter variations on model predictions, and identify influential model parameters. One linear model (Model 1, control) and 2 target-mediated models (Models 2 and 3) were evaluated over a range of dose levels. Simulations were conducted with model parameters being perturbed at the higher and lower ends from literature mean values. Profiles of free plasma drug concentrations and their partial derivatives with respect to each parameter vs time were analyzed. Perturbations resulted in altered outputs, the extent of which reflected parameter influence. The model outputs were highly sensitive to perturbations of linear disposition parameters in all 3 models. The equilibrium dissociation constant (K(D)) was less influential in Model 2 but was influential in the terminal phase in Model 3, highlighting the role of K(D) in this region. An equation for Model 3 in support of the result for K(D) was derived. Changes in the initial receptor concentration [R(tot) (0)] paralleled the observed effects of initial plasma volume (V(c)) perturbations, with increased influence at higher values. Model 3 was also sensitive to the rates of receptor degradation and internalization. These results suggest that informed sampling may be essential to accurately estimate influential parameters of target-mediated models.

Mesh:

Substances:

Year:  2007        PMID: 17614360      PMCID: PMC2751407          DOI: 10.1208/aapsj0902020

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  12 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

2.  Sensitivity analysis of pharmacokinetic parameters in one-compartment models.

Authors:  G Wu
Journal:  Pharmacol Res       Date:  2000-04       Impact factor: 7.658

3.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

4.  Pharmacokinetics of recombinant human leukemia inhibitory factor in sheep.

Authors:  Alicia M Segrave; Donald E Mager; Susan A Charman; Glenn A Edwards; Christopher J H Porter
Journal:  J Pharmacol Exp Ther       Date:  2004-02-10       Impact factor: 4.030

5.  Sensitivity analysis for physiologically based pharmacokinetic models.

Authors:  D M Hetrick; A M Jarabek; C C Travis
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

Review 6.  Target-mediated drug disposition and dynamics.

Authors:  Donald E Mager
Journal:  Biochem Pharmacol       Date:  2006-02-15       Impact factor: 5.858

7.  A review of techniques for parameter sensitivity analysis of environmental models.

Authors:  D M Hamby
Journal:  Environ Monit Assess       Date:  1994-09       Impact factor: 2.513

8.  Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis.

Authors:  I A Nestorov; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

9.  Effect of parameter variability on physiologically-based pharmacokinetic model predicted drug concentrations.

Authors:  P Varkonyi; J V Bruckner; J M Gallo
Journal:  J Pharm Sci       Date:  1995-03       Impact factor: 3.534

Review 10.  Pharmacologic target-mediated drug disposition.

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

View more
  13 in total

1.  Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.

Authors:  Yow-Ming C Wang; Wojciech Krzyzanski; Sameer Doshi; Jim J Xiao; Juan Jose Pérez-Ruixo; Andrew T Chow
Journal:  AAPS J       Date:  2010-10-21       Impact factor: 4.009

Review 2.  Model-based clinical drug development in the past, present and future: a commentary.

Authors:  Holly Kimko; José Pinheiro
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Asymptotic analysis of a TMDD model: when a reaction contributes to the destruction of its product.

Authors:  Lida I Michalaki; Dimitris A Goussis
Journal:  J Math Biol       Date:  2018-04-19       Impact factor: 2.259

4.  Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.

Authors:  Martin Johnson; Magdalena Kozielska; Venkatesh Pilla Reddy; An Vermeulen; Cheryl Li; Sarah Grimwood; Rik de Greef; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

5.  Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition.

Authors:  Anshu Marathe; Scott Van Wart; Donald E Mager
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-17       Impact factor: 2.745

6.  Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice.

Authors:  Anson K Abraham; Leonid Kagan; Sarmishtha Kumar; Donald E Mager
Journal:  J Pharmacol Exp Ther       Date:  2010-04-20       Impact factor: 4.030

7.  Use of a local sensitivity analysis to inform study design based on a mechanistic toxicokinetic model for γ-hydroxybutyric acid.

Authors:  Melanie A Felmlee; Wojciech Krzyzanski; Bridget L Morse; Marilyn E Morris
Journal:  AAPS J       Date:  2011-03-09       Impact factor: 4.009

8.  Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals.

Authors:  Wojciech Krzyzanski; Liviawati Sutjandra; Juan Jose Perez-Ruixo; Bethlyn Sloey; Andrew T Chow; Yow-Ming Wang
Journal:  Pharm Res       Date:  2012-12-19       Impact factor: 4.200

9.  Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models.

Authors:  Xiaoyu Yan; Donald E Mager; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-10       Impact factor: 2.745

10.  Target-mediated disposition model describing the dynamics of IL12 and IFNγ after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice.

Authors:  Zinnia Patricia Parra-Guillen; Alvaro Janda; Pilar Alzuguren; Pedro Berraondo; Ruben Hernandez-Alcoceba; Iñaki F Troconiz
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.